Hot Features
プレミアム
Emergent Biosolutions Inc (EBS)
NYSE
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-01 | Ms. Sujata T. DayalIndependent Director | -13.76k | 115.61k | Automatic Disposition | 8.36 - 8.94 | 100.56k | -12.04% |
| 2026-04-30 | Mr. Keith A. KatkinIndependent Director | -15.48k | 128.18k | Automatic Disposition | 8.28 | 96.29k | -13.85% |
| 2026-05-01 | Mr. Donald W. DeGolyerIndependent Director | -15.48k | 129.99k | Automatic Disposition | 8.36 - 8.96 | 129.72k | -10.66% |
| 2026-05-01 | Dr. Kathryn C. ZoonIndependent Director | -17.20k | 144.45k | Automatic Disposition | 8.36 - 8.97 | 79.94k | -17.71% |
| 2026-04-01 | Mr. Paul A. WilliamsSVP of Products Business | -4.00k | 33.76k | Automatic Disposition | 8.44 | 62.68k | -6.00% |
| 2025-05-07 | Mr. Richard S. LindahlExec. VP & CFO | -40.28k | 0.00 | Other Derivative Disposition | 48.33 - 61.01 | 0.00 | -100.00% |
| 2026-03-05 | Mr. Joseph C. PapaCEO, President & Director | -37.06k | 312.74k | Sale to Issuer | 8.44 | 305.45k | -10.82% |
| 2026-03-05 | Mr. Simon C. LowryChief Medical Officer and Head of Research & Development | -10.64k | 89.77k | Sale to Issuer | 8.44 | 16.48k | -39.22% |
| 2026-03-05 | Ms. Jessica PerlSenior VP, Corporate Secretary & General Counsel | -6.47k | 54.56k | Sale to Issuer | 8.44 | 61.00k | -9.58% |
| 2026-03-05 | Mr. William HartzelSVP of Manufacturing & Bioservices | -9.49k | 80.12k | Sale to Issuer | 8.44 | 87.19k | -9.82% |
| 2026-03-05 | Mr. Paul A. WilliamsSVP of Products Business | -9.40k | 79.31k | Sale to Issuer | 8.44 | 66.68k | -12.35% |
| 2026-03-05 | Mr. Richard S. LindahlExec. VP & CFO | -23.65k | 199.61k | Sale to Issuer | 8.44 | 215.37k | -9.89% |
| 2026-03-05 | Ms. Coleen GlessnerExec. VP of Quality, Ethics & Compliance | -8.20k | 69.20k | Sale to Issuer | 8.44 | 104.11k | -7.30% |
| 2026-03-01 | Mr. Richard S. LindahlExec. VP & CFO | -683.00 | 5.57k | Sale to Issuer | 8.15 | 239.02k | -0.28% |
| 2026-03-01 | Mr. Paul A. WilliamsSVP of Products Business | -116.00 | 945.40 | Sale to Issuer | 8.15 | 76.08k | -0.15% |
| 2026-03-01 | Ms. Coleen GlessnerExec. VP of Quality, Ethics & Compliance | -313.00 | 2.55k | Sale to Issuer | 8.15 | 112.31k | -0.28% |
| 2026-02-09 | Ms. Jessica PerlSenior VP, Corporate Secretary & General Counsel | -918.00 | 10.13k | Sale to Issuer | 11.03 | 67.47k | -1.34% |
| 2026-02-06 | Ms. Coleen GlessnerExec. VP of Quality, Ethics & Compliance | -31.70k | 346.15k | Sale to Issuer | 10.92 | 112.62k | -21.96% |
| 2026-02-06 | Mr. William HartzelSVP of Manufacturing & Bioservices | -6.40k | 69.90k | Sale to Issuer | 10.92 | 96.68k | -6.21% |
| 2026-02-06 | Mr. Paul A. WilliamsSVP of Products Business | -9.68k | 105.67k | Sale to Issuer | 10.92 | 76.19k | -11.27% |
| 2026-02-06 | Mr. Richard S. LindahlExec. VP & CFO | -51.80k | 565.62k | Sale to Issuer | 10.92 | 239.70k | -17.77% |
| 2025-12-14 | Mr. Simon C. LowryChief Medical Officer and Head of Research & Development | -3.54k | 40.43k | Sale to Issuer | 11.41 | 6.28k | -36.05% |
| 2025-12-05 | Mr. Ronald B. Richardインサイダー | -25.75k | 177.09k | Derivative Exercise and Sale | 5.02 - 11.90 | 64.01k | - |
| 2025-12-05 | Mr. Ronald B. Richardインサイダー | -7.10k | 85.99k | 売り | 12.11 | 64.01k | -9.98% |
| 2025-11-11 | Mr. William HartzelSVP of Manufacturing & Bioservices | -610.00 | 6.64k | Sale to Issuer | 10.88 | 103.08k | -0.59% |
| 2025-11-10 | Mr. Donald W. DeGolyerIndependent Director | -17.80k | 187.62k | Automatic Disposition | 10.54 | 45.90k | -27.95% |
| 2025-11-07 | Ms. Sujata T. DayalIndependent Director | -8.55k | 85.52k | Automatic Disposition | 10.00 | 54.58k | -13.55% |
| 2025-10-15 | Mr. Richard S. LindahlExec. VP & CFO | -5.00k | 47.95k | Sale to Issuer | 9.60 | 291.50k | -1.68% |
| 2025-08-15 | Dr. Kathryn C. ZoonIndependent Director | -7.09k | 62.85k | Automatic Disposition | 8.87 | 37.40k | -15.93% |
| 2025-08-12 | Mr. Donald W. DeGolyerIndependent Director | -7.84k | 67.83k | 売り | 8.65 | 24.14k | -24.52% |
| 2025-07-11 | Mr. William HartzelSVP of Manufacturing & Bioservices | -4.26k | 31.38k | Sale to Issuer | 7.36 | 103.69k | -3.95% |
| 2025-06-08 | Ms. Coleen GlessnerExec. VP of Quality, Ethics & Compliance | -1.25k | 8.28k | Sale to Issuer | 6.63 | 174.93k | -0.71% |
| 2025-06-08 | Mr. William HartzelSVP of Manufacturing & Bioservices | -1.17k | 7.74k | Sale to Issuer | 6.63 | 107.96k | -1.07% |
| 2025-06-08 | Mr. Paul A. WilliamsSVP of Products Business | -464.00 | 3.08k | Sale to Issuer | 6.63 | 85.87k | -0.54% |
| 2025-06-08 | Mr. Richard S. LindahlExec. VP & CFO | -2.73k | 18.12k | Sale to Issuer | 6.63 | 296.49k | -0.91% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
